CEO
Charlie is a highly experienced healthcare executive with 30 years of leadership and management experience. Most recently, Charlie was Chief Executive Officer at DCI Health Technology Inc., which provides hospitals with smart digital products that improve patient safety, healthcare quality, and efficiency. While there, Charlie was responsible for launching the company’s U.S. strategic initiatives, driving revenue, and profitability growth. Prior to DCI, Charlie was Senior Vice President of Sales and Marketing for Sotera Wireless Inc., a medical device company that specializes in the development and sales of a wireless, wearable vital sign monitoring platform that allows for continuous monitoring. Within two years, Charlie grew the client base from seven hospitals to more than 55, and grew revenue by more than 75 percent year-over-year. Previously, Charlie was President and Co-Founder of Watermark Medical, where he successfully pioneered the home sleep testing industry by selling diagnostic sleep apnea testing equipment to the primary care and hospital markets. While there, Charlie led the merger with another company that provided both sleep and EEG services. Additionally, he has served as Executive Vice President of Sales at PDSHeart – CardioNet.
CHIEF MEDICAL OFFICER
Dr. Slater serves as Chief Medical Officer for Stratus, having worked in the field of epilepsy for more than 27 years. He served as Director of the Texas Comprehensive Epilepsy Program from 2004 to 2018, growing the center from a single neurologist and neurosurgeon to one of the largest epilepsy surgery programs in the country. He has served as an investigator for numerous clinical trials of novel anticonvulsants and medical devices. His early research work focused on the potential for applying techniques of the developing field of artificial neural networks to classification problems in clinical neurophysiology. These studies demonstrated the ability of such networks to distinguish disease states with a level of discrimination higher than achieved through statistical or human visual analysis. While the architectures have evolved and now such analyses are commonplace, these were the first such studies of their kind. His more recent research has focused on changes to brain electrical activity related to drowsiness.
CHIEF FINANCIAL OFFICER
Patricia, a CPA, graduated from Bradley University and began her career as an auditor in public accounting. She transitioned to the manufacturing sector and has spent the last 20 years working in healthcare. Most recently, Patti was CFO of HealthTrackRx, a clinical laboratory that provided programs for clinicians supporting responsible opioid prescribing decisions, as well as Med Fusion Clinical Laboratory, a full-service laboratory and clinical trials organization focused on cancer care. Previously, she held multiple positions at Ameripath, an anatomic pathology and esoteric laboratory. As Vice President of Finance and Billing, Hospital Division, she was responsible for the finance and billing of 28 pathology practices servicing 380 hospitals across the United States. Both Ameripath and Med Fusion were acquired by Quest Diagnostics. Patti is thrilled to be part of a market-leading healthcare provider that enhances the quality of clinical diagnoses and improves patients’ lives.
CHIEF COMMERCIAL OFFICER
Lane serves as Chief Commercial Officer for Stratus. In this role, he is charged with guiding the organization’s growth strategies and ensuring the company continues to evolve and meet the needs of customers. Lane has led growth efforts for several Fortune 500 companies, most recently as the Vice President of Business Development for Tenet Healthcare, the second largest investor owned hospital company in North America. Before joining Tenet, Lane was the Vice President of Business Development and Integration for Health Management Associates, which owned and operated over 70 hospitals across the U.S. He started his career in healthcare with Novartis Pharmaceuticals in 2002, serving in various leadership roles over his 9-year tenure. Lane is a proud graduate of the University of Alabama.
CHIEF COMPLIANCE OFFICER
David serves as Chief Compliance Officer for Stratus. In this role, he oversees the Corporate Compliance Program to ensure adherence to healthcare regulations at all levels. David works within all departments to instill a strong sense of ethics and compliance within the complex and ever evolving world of healthcare regulations. David is an attorney as well and has handled a broad scope of transactional and litigation matters in private practice. He has appeared in Federal courts in Maryland, Massachusetts, Kansas, and Florida. He has extensive trial experience in Maryland state courts. David has been involved in healthcare for the past 20 years. He served as General Counsel to PDS Heart at its founding and oversaw its acquisition by Cardionet, now Biotel. David served as Chief Compliance Officer at Watermark Medical at its founding and helped pioneer the home sleep testing market. During his tenure he oversaw the company grow to become the largest provider of sleep diagnostic services in the country. He also led acquisitions of companies that provided EEG testing and DME products.
VICE PRESIDENT OF MARKETING
Jennifer joined Stratus in September 2019, as Vice President of Marketing. With several decades of experience in the healthcare industry, including positions at Johnson & Johnson, St. Jude Medical (now Abbott), HealthTrackRx, and Tagnos, Jennifer is a marketing leader with a proven track record for creating global marketing solutions that deliver sales results and drive strategic business initiatives. Jennifer has expertise in the identification of key market drivers, as well as the development and communication of unique selling propositions across customer segments and channels. She’s been recognized for developing collaborative, cross-functional, and cross-cultural relationships to achieve corporate objectives.
SENIOR DIRECTOR OF HUMAN RESOURCES
Felicia Summerville, MSc, is the Senior Director of Human Resources for Stratus. Felicia has over 25 years of progressive experience overseeing key aspects of corporate HR and human relations functions. She has operated in small, and medium-to-large corporate environments servicing up to 5,000+ employees within various industries. Ms. Summerville holds a Bachelor of Science Degree in CJUS/Psychology from the UNT and a Master of Science Degree in HR and Business from Amberton University. Additionally, Felicia has served as a Classification Officer for the Dallas County Sheriff’s Department and has her Texas Commission on Law Enforcement Standards and Education (TCLOSE) Certification. Ms. Summerville is also a member of the Texas Diversity Council, Dallas HR, Society of Human Resources Management, and an alumnus of North Texas Leaders & Executives Advocating Diversity (LEAD).
CHIEF MEDICAL OFFICER
Dr. Slater serves as Chief Medical Officer for Stratus, having worked in the field of epilepsy for more than 27 years. He served as Director of the Texas Comprehensive Epilepsy Program from 2004 to 2018, growing the center from a single neurologist and neurosurgeon to one of the largest epilepsy surgery programs in the country. He has served as an investigator for numerous clinical trials of novel anticonvulsants and medical devices. His early research work focused on the potential for applying techniques of the developing field of artificial neural networks to classification problems in clinical neurophysiology. These studies demonstrated the ability of such networks to distinguish disease states with a level of discrimination higher than achieved through statistical or human visual analysis. While the architectures have evolved and now such analyses are commonplace, these were the first such studies of their kind. His more recent research has focused on changes to brain electrical activity related to drowsiness.
CHIEF MEDICAL OFFICER, CENTER FOR MENTAL HEALTH
CLINICAL PROFESSOR, NEUROLOGY & PSYCHIATRY, UNIVERSITY OF COLORADO SCHOOL OF MEDICINE
CLINICAL PROFESSOR, PSYCHIATRY, NEUROLOGY, PHYSICAL MEDICINE & REHABILITATION, BAYLOR COLLEGE OF MEDICINE
SENIOR SCIENTIST, BRAIN INJURY RESEARCH CENTER AT TIRR MEMORIAL HERMANN
UNIVERSITY OF MICHIGAN MEDICAL SCHOOL, MD
Over the last 20 years, Dr. Arciniegas’ clinical work and patient-oriented research as a subspecialist in behavioral neurology and neuropsychiatry has focused on the phenomenology, neurobiology, and rehabilitation of the cognitive and noncognitive neuropsychiatric sequelae of traumatic brain injury (TBI), other acquired brain injuries and neurodegenerative disorders, and neurodevelopmental conditions, including schizophrenia spectrum and other psychotic disorders. He has authored more than 115 peer-reviewed journal articles, over 130 peer-reviewed abstracts, nearly three-dozen book chapters, and more than 40 additional media-related works for professional and lay audiences. He is editor of the Journal of Neuropsychiatry and Clinical Neurosciences and a member of multiple editorial and scientific review boards in the clinical neurosciences. In addition to his administrative, clinical, and academic duties, Dr. Arciniegas serves as chairman and CEO of the International Brain Injury Association, is President-elect of the International Neuropsychiatric Association, and contributes his efforts to governmental and nongovernmental organizations striving to improve the lives of persons and families affected by brain injuries.
DIRECTOR, UNIVERSITY OF SOUTH FLORIDA/TAMPA GENERAL HOSPITAL COMPREHENSIVE EPILEPSY PROGRAM
PROFESSOR, NEUROLOGY AT USF
Selim Benbadis, MD, is a board-certified epileptologist and clinical neurophysiologist. Benbadis graduated from medical school at the University of Nice (Nice, France), where he completed a residency in family medicine. He completed his neurology residency at the Cleveland Clinic Foundation where he stayed an additional 2 years to complete a fellowship in epilepsy, EEG, and sleep medicine. Dr. Benbadis is currently a professor of neurology at the University of South Florida and the Director of the University of South Florida /Tampa General Hospital Comprehensive Epilepsy Program. His interests are in the diagnosis and management of seizures that are difficult to control and the misdiagnosis of epilepsy. He has authored more than two hundred articles and book chapters. He also has a strong interest in medical writing and editing and serves on several editorial boards. Finally, he has a strong interest in education, serves as faculty on numerous courses each year, and has received several teaching awards.
MEDICAL DIRECTOR, BIOGEN
TUFTS UNIVERSITY SCHOOL OF MEDICINE, MD
Dr. Cochrane completed his residency in neurology in the Partners Neurology Program at Massachusetts General Hospital and Brigham and Women’s Hospital (BWH). He then finished a fellowship in neuromuscular medicine and electromyography at BWH. He completed the Fellowship in Medical Ethics at Harvard Medical School, and then served as a faculty fellow at the Safra Foundation Center for Ethics at Harvard University. Since 2005, he has worked as an attending neurologist specializing in neuromuscular disease at BWH. He also worked as senior ethics consultant at BWH and served on the Partners IRB. He taught medical ethics to Harvard Medical students, residents, faculty, and nursing staff at all levels, and was the first director of neuroethics at the Center for Bioethics at Harvard Medical School. In 2018, Dr. Cochrane joined Biogen as the medical director.
Omotola Hope, MD, is a board-certified neurologist who specializes in treating epilepsy and other types of seizures. Hope is a graduate of the University of Pennsylvania School of Medicine. She completed an internship in internal medicine at North Shore University Hospital in Manhasset, N.Y., and her residency in neurology at Yale New Haven Hospital in Connecticut. She also completed a fellowship in epilepsy at Yale New Haven Hospital, as well as a research fellowship through the Robert Wood Johnson Clinical Scholars Program at Yale University School of Medicine. She currently treats patients at Houston Methodist Sugar Land and was previously at Memorial Hermann Hospital, where she also served as an associate professor of neurology and program director of the epilepsy fellowship at McGovern Medicine School at the University of Texas Health Science Center – Houston.
DIRECTOR, MID-ATLANTIC EPILEPSY AND SLEEP CENTER
CLINICAL PROFESSOR, NEUROLOGY, GEORGE WASHINGTON UNIVERSITY
CAMBRIDGE UNIVERSITY, MD
Dr. Klein’s clinical research includes novel treatments of epilepsy, dietary treatments of epilepsy in adults, prevention of epilepsy after traumatic brain injury, the effect of sex and stress hormones on epilepsy, and women with epilepsy.
He has received grants from the National Institutes of Health and the American Epilepsy Society, and investigator-initiated study grants from several pharmaceutical companies. Dr. Klein has published more than 45 peer-reviewed articles and contributed chapters to several books on epilepsy. He has been a member of the American Epilepsy Society Scientific Program Committee, Treatment Committee, and the Health Reform Task Force. Currently, he acts as a reviewer for a number of neurological, epilepsy and endocrinological journals and is chair of the AES Corporate Advisory Council. He is the Co-Founder and Co-Chair of the North American Consortium of Private Epilepsy Practices.
PROFESSOR, NEUROLOGY, UNIVERSITY OF CALIFORNIA SAN FRANCISCO
MEDICAL DIRECTOR, UCSF SEIZURE DISORDERS SURGERY PROGRAM
LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE NEW ORLEANS, MD
Dr. Knowlton’s research focuses on discovering advances in clinical neurophysiology and brain imaging that can affect decision-making in treatment of seizure disorders and brain tumors. The main focus of his work is to determine which advanced imaging discoveries should be moved to clinical application. He has worked specifically to improve and validate the clinical utilization of multiple modalities of brain imaging, including high-resolution magnetic resonance imaging (MRI), MR spectroscopy/spectroscopic imaging (MRS/MRSI), positron emission tomography (PET), magnetic and electrical source imaging (MSI/ESI), and ictal single photon emission computed tomography (SPECT). From the very beginning of his career, Dr. Knowlton has taken advantage of combining multiple imaging modalities to allow comparison of the relative merits for each test to determine if novel information can be discerned and measure whether purported advances improve patient care.
ASSISTANT PROFESSOR OF NEUROLOGY, HARVARD MEDICAL SCHOOL
DIRECTOR OF CLINICAL NEUROPHYSIOLOGY AND ADULT EPILEPSY FELLOWSHIP, BETH ISRAEL DEACONESS MEDICAL CENTER
MICHAEL G. DEGROOTE SCHOOL OF MEDICINE, MD
Dr. Pang is an Assistant Professor of Neurology at Harvard Medical School and Director of the Clinical Neurophysiology and Adult Epilepsy Fellowship at Beth Israel Deaconess Medical Center. She is also Director of the comprehensive Women’s Health in Epilepsy Program, a collaborative effort across Boston medical institutions to address the special needs of women with epilepsy. Dr. Pang earned her medical degree at Michael G. DeGroote School of Medicine and specializes in the investigation and treatment of epilepsy and status epilepticus. Her clinical research includes work on T-wave alternans in patients with established or new onset epilepsy and the effects of anti-epileptic drugs and seizures on markers of sudden death in patients with epilepsy. She has published more than 20 peer-reviewed clinical papers related to epilepsy in renowned publications such as Experimental Neurology, Clinical Neurophysiology, and Seizure: European Journal of Epilepsy.
PROFESSOR, DEPARTMENT CHAIR OF PSYCHOLOGY, COLORADO STATE UNIVERSITY
COLORADO STATE UNIVERSITY, PH.D.
Since 2013, Dr. Rojas has served as a faculty member in the Department of Psychology at Colorado State University. The primary theme of his work has been the identification of heritable biomarkers in autism, using non-invasive neuroimaging and electrophysiological techniques in first-degree relatives. His specialties include magnetoencephalography, electroencephalography, functional magnetic resonance imaging, autism, and schizophrenia.
ASSOCIATE PROFESSOR OF MEDICINE, DIVISION OF CARDIOVASCULAR MEDICINE, DEPARTMENT OF MEDICINE, HARVARD MEDICAL SCHOOL, BETH ISRAEL DEACONESS MEDICAL CENTER
DIRECTOR OF CARDIOLOGY GRAND ROUNDS, BETH ISRAEL DEACONESS MEDICAL CENTER
UNIVERSITY OF VIRGINIA, PH.D.
Dr. Verrier has investigated sudden cardiac death for more than three decades, having published over 300 original articles. He is inventor of 12 licensed patents for diagnosis and treatment of heart rhythm abnormalities and prediction of sudden cardiac death. During the past six years, he has focused attention on the cardiac effects of epilepsy in close collaboration with Professor Steven Schachter, a pioneer in VNS therapy and past president of AES. Their joint publications in Epilepsia and Epilepsy & Behavior have broken new ground in the study of patients with epilepsy.